Loading, please wait ...


News Analytics

iStock 827581056.
Quench Bio has emerged from stealth mode with $50 million of committed funding, bidding to be the first company to target Gasdermin D (GSDMD) in inflammatory disease indications poorly served by existing drugs.
Google

Subject Matter

  • Science and technology 64.71%
  • Healthcare 35.29%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions